retatrutide phase 2 study results Lilly's triple agonist delivers up to 71.2 lbs of weight loss Phase III retatrutide study demonstrates

That framing is misleading

In human peripheral blood cells, liraglutide has been reported to decrease the production of pro-inflammatory cytokines (TNF-, IL-1, and IL-6), and activation of macrophages (Hogan et al., 2014

Editors note: This story has been updated to clarify that a U.S

Common GLP-1 Drugs You Will Hear About Indian Note: Dulaglutide (Trulicity) and Liraglutide (Victoza) are available in India

CrossRef Electrochemical Biosensor Based on a Tetrahedral DNA Nanostructure and an AND Logic Gate-Regulated Cascade Amplification System for Parallel Detection of Dual Disease Biomarkers Li Yang, Ya Zhou, Huimin Li, Yao Gao, Xiaoli Xiong, Tao Zhang, Liping Zhu, Xiurong Yang ACS Sensors .2025